Blue Owl Capital Holdings LP
Annual return '25
+52.5%
SPY '25
+17.7%
Alpha
+34.8ptsvs SPY
Invested
$372.2M
Holdings
61
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 98%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$AKTS
AKTIS ONCOLOGY INC
Held since at least Q1 2024
15.6%
02
$LRMR
LARIMAR THERAPEUTICS INC
Held since at least Q1 2024
8.8%
03
$ENGN
ENGENE HOLDINGS INC
Held since at least Q1 2024
8.3%
04
$NCDL
NUVEEN CHURCHILL DIRECT LEND
Held since at least Q1 2024
7.5%
05
$CGEM
CULLINAN THERAPEUTICS INC
Held since at least Q1 2024
7.5%
06
$OBDC
BLUE OWL CAPITAL CORPORATION
Held since at least Q1 2024
6.2%
07
$MPLT
MAPLIGHT THERAPEUTICS INC
Held since at least Q1 2024
5.6%
08
$CMPX
COMPASS THERAPEUTICS INC
Held since at least Q1 2024
4.3%
09
$CNTX
CONTEXT THERAPEUTICS INC
Held since at least Q1 2024
3.7%
10
$HLLY
HOLLEY INC
Held since at least Q1 2024
3.6%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:36 UTC.